OraSure Technologies, Inc.

NASDAQ:OSUR

Medical - Instruments & Supplies

Healthcare
$3.59 -3.47%

-$0.16 today

Market cap
$247.88M
Beta
1.01
P/E (TTM)
-4.0
EPS (TTM)
-$1.08
52W Low $2.08High $4.58

Volume 0.49M

Average 0.61M

OSUR Free Cash Flow

Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.

OraSure Technologies, Inc.NASDAQ: OSUR

Free Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Free cash flow dips below year-ago levels

Q1 FY2026 free cash flow of $14.81M (cash outflow) fell 26.5% year over year, behind the +2657.8% change in trailing-twelve-month free cash flow. Sequentially, it rose 49.3% from the prior quarter. Over 3 fiscal years it compounded at -92.2% a year.

Context

  • Free cash flow amounted to 0.0% of revenue in FY2025, down 12.6 pp from a year earlier.
  • Free cash flow increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -26.5% toward the trailing-twelve-month pace of +2657.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$14.81M+49.3% QoQ
Last fiscal yearDec 2025
-$53.22K-100.2% YoY
LTMMar 2026
-$47.88M+2657.8% YoY
Free Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-26.5%——
1 year-100.2%——
3-year CAGR-92.2%——
5-year CAGR——
10-year CAGR——

Free Cash Flow history

USD · from the cash flow

Latest · FY2025
(53.22K) USD
Year-over-year change
-100.2%

Free Cash Flow vs competitors

How OSUR compares with its peers on the latest reported figures

  • Peers report in different currencies, so free cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +2657.8% is the highest of 8, against a peer median of +3.5%.
  • Free cash flow amounts to 42.4% of revenue for OSUR, versus a peer median of 120.6%.
OSUR Competitors
Free Cash Flow for OSUR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CATXPerspective Therapeutics, Inc.LTM Mar 2026$107.32M USD+3.5%+96.9%17365.9%
NYXHNyxoah S.A.LTM Mar 2026€73.28M EUR+23.5%+14.8%449.1%
TARAProtara Therapeutics, Inc.LTM Mar 2026$63.05M USD+56.6%+28.6%—
NAUTNautilus Biotechnology, Inc.LTM Mar 2026$51.43M USD-12.1%+2.6%—
OSUROraSure Technologies, Inc.LTM Mar 2026$47.88M USD+2657.8%-92.2%42.4%
PROFProfound Medical Corp.LTM Mar 2026$38.97M USD+44.5%+14.8%206.5%
PREPrenetics Global LimitedLTM Mar 2026$34.14M USD——30.0%
NTHINeonc Technologies Holdings, Inc.LTM Mar 2026$21.71M USD———
STIMNeuronetics, Inc.LTM Mar 2026$13.58M USD-63.6%-14.6%9.0%
UTMDUtah Medical Products, Inc.LTM Mar 2026$13.02M USD-6.0%-11.0%34.7%
Peer median (excluding OSUR) —+3.5%+14.8%120.6%

Competitors are the stored peer set for OSUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(23M)(17.93M)53.66M(19.5M)(68.73K)
Depreciation & Amortization12.5M15.54M20.94M10.87M10.19K
Deferred Income Tax1.03M(1.65M)102K(657K)(103)
Stock-Based Compensation7.81M11.62M10.73M11.92M10.15K
Change in Working Capital(38.44M)(70.56M)45.76M18.82M(6.8M)
Accounts Receivables(6.45M)(25.16M)31.12M15.87M1.95M
Inventory(27.94M)(43.05M)48.23M13.1M3.56M
Accounts Payables3.23M3.96M(26.98M)(7.58M)(1.72M)
Other Working Capital(7.28M)(6.32M)(6.61M)(2.57M)(10.59M)
Other Non-Cash Items4.72M15.79M10.4M5.92M6.8M
Operating Cash Flow(35.38M)(47.2M)141.58M27.37M(49.02K)
Capital Expenditures(48.12M)(63.91M)(10.3M)(3.8M)(4.2K)
Acquisitions (Net)0121K0(5.04M)(3.61K)
Purchases of Investments(25.82M)(22.87M)(74.65M)(53.24M)0
Sales of Investments67.93M47.42M102.44M53.05M0
Other Investing Activities513K60.33M48.67M(30M)1K
Investing Cash Flow(5.5M)21.09M66.15M(39.03M)(6.81K)
Debt Repayment(686K)(1.38M)(1.35M)(842K)(61K)
Common Stock Issued00000
Common Stock Repurchased(2.11M)(2.25M)(1.9M)(3.55M)(15.04M)
Dividends Paid00000
Other Financing Activities(18K)(193K)223K214K15.08M
Financing Cash Flow(2.82M)(3.83M)(3.02M)(4.18M)(16.94K)
Effect of Forex Changes(340K)(2.84M)1.71M(6.82M)4.29K
Net Change in Cash(44.04M)(32.78M)206.43M(22.64M)(68.49K)
Free Cash Flow(83.5M)(111.11M)131.28M23.58M(53.22K)

OraSure Technologies, Inc.

NASDAQ:OSUR

Intrinsic Alpha fair value

Locked

Current Price

$3.59

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.